NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tirzepatide vendors

CellupepTirzepatide

7 testslatest 9 Aug 2026$0.48/mg median
Message on WhatsApp+85246601450Intelligence report26 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tirzepatide from Cellupep? Mail in a sample (US only) and let us test it for free.

Test my supply
+8 more ↓
79%
Finnrick rating
#130 of 277 Tirzepatide vendors
5 of 6 classifiable tests passed
natural 83% · customers 4.5★ (8)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Cellupep's purity-focus record is strongest in GHK-Cu and Tirzepatide, with Retatrutide still comparatively strong despite late-2026 identity and purity setbacks. BPC-157 shows repeated purity misses, while TB-500 and Tesamorelin are mixed; recent volume is useful, but absent batch identifiers and dispersed results keep confidence uneven.

methodology →
vendor intelligence report
Vendor Intelligence Report: Cellupep

Corporate and domain records point to a recent, privacy-protected operation behind Cellupep’s manufacturer-style claims. The full report follows the COA gallery, UK/HK contact layer, European storefront, and mixed fulfillment trail without relying on vendor screenshots.

26 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
16 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
84%
5
2
Tirzepatideselected
$0.48
79%
7
3
Retatrutide
$1.00
77%
18
4
Tesamorelin
$2.00
49%
4
5
BPC-157
$0.75
42%
6
6
TB-500
$1.26
41%
4
7
Glutathione
$0.01
-
0
8
HGH
$1.33
-
0
9
Ipamorelin
$1.10
-
0
10
KPV
$0.50
-
0
11
MOTS-c
$0.68
-
0
12
NAD+
$0.01
-
0
13
PT-141
$0.75
-
0
14
Semaglutide
-
-
0
15
SS-31
$0.84
-
0
16
Wolverine
$0.85
-
0
Contact channels
4 channels on file
WhatsApp+85246601450WhatsApp+85246610343Websitecellupeptide.comEmailNot verifiedsupport@yourdomain.tld
Rating trend
Tirzepatide from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Nov 2025: 79%13 Dec 2025: 79%20 Feb 2026: 81%20 Jul 2026: 83%3 Aug 2026: 84%9 Aug 2026: 80%29 Oct 2026: current 79%79%79%Nov 25Oct 26
Showing Tirzepatide tests only
Cellupep Tirzepatide test history
7 tests · 5 pass · 1 fail · 1 incomplete
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Aug 2026Fail
z9jr94q
Tested
lab nameView COA
3 Aug 2026Pass
ebq2gxd
Tested
lab nameView COA
20 Jul 2026Pass
zqweejd
Tested
lab nameView COA
20 Jul 2026Incomplete
gmxyh3f
Tested
lab nameView COA
20 Feb 2026Pass
v9pwpym
Tested
lab nameView COA
13 Dec 2025Pass
yy4fgdr
Tested
lab nameView COA
17 Nov 2025Pass
qwerhar
Tested
lab nameView COA

About Cellupep test results from Finnrick

Cellupep is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 44 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Cellupep peptides in this dataset are BPC-157 (6 tests), GHK-Cu (5 tests) and Retatrutide (18 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 44 recent tests.

Corrections
0 corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from Cellupep? Mail in a sample (US only) and let us test it for free.

Test my supply